EMILY SMITH: Open Payments
NPI 1720736804 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 15 payments from 7 companies in 2025. Trend: 2023 $78 · 2024 $262 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $95 |
| Lilly USA, LLC | 4 | $89 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| ABIOMED | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, JARDIANCE, GVOKE HYPOPEN, MOUNJARO, AIRSUPRA, Cologuard Collection Kit, FARXIGA, Ozempic.
Industry payments across NM — which companies pay providers there.
